← All trials
NCT05008354
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2020
- Primary completion
- Nov 1, 2021
- Completion date
- Jan 1, 2022
- First posted
- Aug 17, 2021
- Last posted
- Aug 18, 2021
- Enrollment
- 40
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Mazandaran University of Medical SciencesLead sponsor
- Mazandaran University of Medical SciencesSponsor investigator
- Mazandaran University of Medical SciencesCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.